We are often asked how we gain such efficiency in the clinical trial process. We attribute our speed to the Chorus right fit concept -

• Appoint a skilled and experienced single point of contact to each project.
• Utilize global therapeutic and scientific network of experts who have unique expertise or technology specific to the study design.
• Select geographies and site(s) to optimize our clinical trials based on patient population data and regulatory turnaround times.
• Conduct early phase studies in emerging regions.

Key sources of efficiency stem from our philosophy encompassing best practices: make intelligent business decisions and deliver on commitments with diligence.

• Chorus does not have preferred provider vendor relationships. This enables selection of only the most qualified providers for each clinical study, specific to the unique study requirements.
• Chorus has one governance committee that reviews all regulatory and patient safety documentation, therefore can quickly and consistently move through the review and approval process without being encumbered by multiple layers of internal governance reviews.
• Chorus will utilize our vendors' templates, systems, and operating procedures to maintain efficiencies, both internally and externally.

We assign the right experienced staff and service provider, leverage a global network of scientific experts and technologies specific to the molecule, and make data-driven clinical operations decisions.